Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $715.4 million versus the consensus estimate of $685.36 million.

GUIDANCE:

Hologic sees FY2017 EPS of $1.98-$2.02, versus the consensus of $1.98. Hologic sees FY2017 revenue of $3.05-3.08 billion, versus the consensus of $3.06 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.